Your browser doesn't support javascript.
loading
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis: a commentary.
Fonti, Giulia Lavinia; Chimenti, Maria Sole; Greco, Elisabetta; Boffa, Laura; Conigliaro, Paola; Triggianese, Paola; Perricone, Roberto.
Afiliação
  • Fonti GL; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. glfonti@hotmail.it.
  • Chimenti MS; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Greco E; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Boffa L; Department of Neurosciences, MS Centre, Tor Vergata University, Rome, Italy.
  • Conigliaro P; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Triggianese P; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Perricone R; Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Clin Exp Rheumatol ; 39(1): 223, 2021.
Article em En | MEDLINE | ID: mdl-32452349

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos / Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article